Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening ...
The European Randomized study of screening for prostate cancer (ERSPC) demonstrated a reduction in prostate cancer (PC) mortality via PSA-based screening. We evaluated whether treatments for castration resistant PC vary between the trial arms within the …